Item 7.01. Regulation FD Disclosure.
A copy of an Investor Presentation that BioHiTech Global, Inc. (the
"Registrant") may use for upcoming meetings with investors and other interested
parties is attached to this Current Report on Form 8-K as Exhibit 99.1 and is
incorporated by reference herein. Additionally, the Registrant has posted the
slide presentation in the Investor Presentations section of its Investor website
at http://investors.biohitechglobal.com/investor-Presentation. Information
obtained or linked to the foregoing website shall not be deemed to be included
in this Current Report on Form 8-K.
The furnishing of the attached presentation is not an admission as to the
materiality of any information therein. The information contained in the slides
is summary information that is intended to be considered in the context of more
complete information included in the Registrant's filings with the U.S.
Securities and Exchange Commission (the "Commission" ) and other public
announcements that the Registrant has made and may make from time to time by
press release or otherwise. The Registrant undertakes no duty or obligation to
update or revise the information contained in this Current Report on Form 8-K
except to the extent required by applicable law, although the Registrant may do
so from time to time as its management believes is appropriate. Any such
updating may be made through the filing of other reports or documents with the
Commission, through press releases or through other public disclosures. For
important information about forward looking statements, see the slide titled "
Safe Harbor" in Exhibit 99.1 attached hereto. This information should be read in
conjunction with the risk factors and other information contained in the
Registrant's filings with the Commission.
The information in this Current Report on Form 8-K, including Exhibit 99.1
attached hereto, shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of
1933, as amended. The information contained in this Item 7.01 and in the
presentation attached as Exhibit 99.1 to this Current Report shall not be
incorporated by reference into any filing with the SEC made by the Registrant,
whether made before or after the date hereof, regardless of any general
incorporation language in such filing.
This Form 8-K and the Exhibit contain "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. These forward-looking
statements are only predictions and involve known and unknown risks and
uncertainties, many of which are beyond the Registrant's control. These
statements are also based on many assumptions and estimates and are not
guarantees of future performance. These statements may involve known and unknown
risks, uncertainties and other factors which may cause the actual results,
performance or achievements of BioHiTech Global, Inc. to be materially different
from future results, performance or achievements expressed or implied by such
forward-looking statements. BioHiTech Global, Inc. assumes no obligation to
publicly update or revise these forward-looking statements for any reason, or to
update the reasons actual results could differ materially from those anticipated
in these forward-looking statements, even if new information becomes available
in the future. Our actual results may differ materially from the results
anticipated in these forward-looking statements due to a variety of factors,
including, without limitation those set forth as "Risk Factors" in our filings
with the Commission. There may be other factors not mentioned above or included
in the BioHiTech's Commission filings that may cause actual results to differ
materially from those projected in any forward-looking statement. BioHiTech
Global, Inc. assumes no obligation to update any forward-looking statements as a
result of new information, future events or developments, except as required by
securities laws.
Item 9.01. Financial Statements and Exhibits.
Number Description
99.1 BioHiTech Corporate Presentation - September 2021
104 The cover page from this Current Report on Form 8-K, formatted in Inline
XBRL.
© Edgar Online, source Glimpses